Relapse

The Potential of Cannabidiol as a Treatment for Different Substance Use Disorders Substance use disorders, including addiction to drugs and...

Cannabidiol (CBD) has been gaining popularity in recent years for its potential therapeutic benefits in treating a variety of health...

The NKG2D rs1049174 Polymorphism in Donors Predicts Hematopoietic Recovery and Event-Free Survival Following Single-Unit Cord Blood Transplantation in Adults: Insights...

Title: Promising Results: First Patient in Phase 1 Clinical Trial of PMB-CT01 Achieves Complete Remission for Relapsed and Refractory B-cell...

The Potential of CBD in Assisting with Smoking Cessation Smoking is a widespread addiction that affects millions of people worldwide....

Title: The Future of DLBCL Treatment: A Market Scenario Analysis Through 2032 Introduction: Diffuse Large B-Cell Lymphoma (DLBCL) is the...

The Food and Drug Administration (FDA) has recently granted approval for a new drug called Iwilfin (eflornithine) as a maintenance...

Title: NMDP/Be The Match® PTCy Research: Bridging the Gap in Hematopoietic Cell Transplantation between Matched and Mismatched Cases – Insights...

Learn about Genentech’s Efforts to Enhance Multiple Sclerosis Treatment and Increase Diversity in Clinical Trials Multiple sclerosis (MS) is a...

Welcome to The Niche Weekly Reads, your go-to source for the latest updates on cutting-edge scientific advancements and breakthroughs. In...

How Artificial Intelligence Can Assist Smokers in Quitting Smoking Smoking is a global health issue that affects millions of people...

The Potential of GLP-1s as a Treatment for Alcoholism: A Promising Outlook Alcoholism is a chronic and debilitating disorder that...

The Launch of Kesimpta for Multiple Sclerosis Gains Momentum Multiple sclerosis (MS) is a chronic autoimmune disease that affects the...

A Retrospective Study on Different Conditioning Approaches for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndromes with an Excess...

The European Union (EU) has recently approved a groundbreaking targeted therapy for a specific subtype of leukaemia, marking a significant...